Ozone in non-rheumatic locomotor system pathologies
- Тип работы:
- Медицина и здравоохранение
Детальная информация о работе
Выдержка из работы
Биорадикалы и Антижсиданты 2015 Тем 2. Nsl
OZONE IN XON-KHELTY1ATIC LOCOMOTOR SYSTEM PATHOLOGIES A. Alexandre, J. Baezii NocL V. Sbeel Kumar
International Scientific Committee of Ozone Therapy, Madrid, Spain
Статья опубликована с разрешения Международного научного комитета, но проблемам озонотерапии (The Scientific International Committee of Ozone T/i erapy — ISC03, u n it1, aeprom o. org/enA 5 с oS. php)
В обзоре, включающем анализ достижений озонотерапии за последние два десятилетня, рассмотрено современнее состояние и применимость метода е ревматологии. неврологии. нейрохирургии и ортопедии. Рассмотрены возможности использования медицинского озона при теидопатнях, остеоаргритах нт. д. Отдельное внимание уделено озонотерапии неврологической патологии (в частности, туннельным синдромам), заболевании позвоночника. Обседаются способы введения озона и оптимальные его дозы. Кратко рассмотрены противопоказания к озонотерапии для контингента пациентов с неревматичекои патологией опорно-двигательного аппарата.
Ключевые слова: озон, озонотерапия. заболевания позвоночника, тендопатии. остеоартрит. туннельные синдромы
Although bone and joint diseases were not one of the first indications of ozone therapy, after Dr Verga'-s  and Dr Riva Sansevenno'-s papers , several following publications [3−7] encouraged doctors to use ozone for treating these kind of pathologies. Unfortunately, the first publication on this pathology . more than 30 years before Dr Verga'-s one. remained unnoticed.
Results have been so positive that nowadays the majority of papers about ozone therapy are related to these problems and the highest level of evidence on ozone therapy effectiveness is also related to them. According to the systematic review and metaanalysis of Magalhaes et al , for low back pain:
— paravertebral ozone therapy has a level of evidence II-1 (Evidence obtained from systematic review of randomized trials or several randomized clinical trials) with grade of recommendation ЕВ (strong recommendation, with moderate quality evidence), and
— intradiscal ozone therapy has a level of evidence II-3 (evidence obtained from multiple time series or dramatic results in uncontrolled trials) with grade of recommendation 1С: (strong recommendation, low-quality evidence)
In this document, the authors will show the rationale of using ozone ш these diseases and what we can expect from it. based on publications and their own experience in the past two decades.
The development of ozone therapy has been based on empirical science, so basic investigation to determine the best dose and protocols of administration was performed after clinical use shoived the optimal dosmg in a non-controlled environment. The first work about this  was carried out in mice pads using a standard inflammatory model
BHOpiOHKiLTEi H AHTHOKCHjaHTti 2015 TCH 2.
with capsaicin, that proved 20 ug-'-mL to be the best anti-inflammatory dose for soft tissue pathology used as local injections.
This optimal concentration has been confirmed by Dr Iliakis'-s publications  as being, not only effective but also safe  for the tissues. Late works by Prof. Yu Bin  prove that one week injection of ozone at 20 |ig/mL was tlie most antiinflammatory closing compared with 10, 30 and 40 |Ag/mL in rabbit model.
We need more animal investigation and more controlled studies in human to narrow the wide therapeutic approach of ozone therapy in musculoskeletal pathologies, but we have a rationale start point in the above publications, that also support the most widely used protocols for treating these diseases. Regarding disc-radicular conflict (CDR), the experimental investigation m animals lias been more deeply developed, using models with rabbit [14, 15]. dog [16−18], lamb [1?] and pig [20. 21]. Even some publications [22−24] show histological changes after ozone administration in humans with unsuccessful result submitted to surgery. These studies have provided confirmation of empirical use of ozone for disc diseases and have improved do sine and safetv [25. 26].
Many other clinical controlled and non-controlled studies have been published in the last 15 years showing us the way to treat spme diseases, but only latest papers [9, 27. 23] prove with high evidence level the effectiveness and safely7 of ozone injections to treat CDR.
We will try-'- to summarize this information and offer an evidence based guideline for these groups of pathologies. The reader must notice that except for disc herniation, the studies on other indications have a low level of evidence, so the use of ozone should be done on a compassionate basis, when standard well documented treatments have failed, are not applicable to the patient or the patients resign to them. We advice to use official informed consent from the scientific associations are they are usually lex-artis based and formally reviewed by a lawyer.
Many doctors believe that strict aseptic measures are not necessary as ozone is a strong antiseptic. This is absolutely false . as ozone is quickly tampered by antioxidants substances in the plasma and interstitial water. Moreover, many bacterias have antioxidant defenses against oxidant molecules. For this reason, strict aseptic measures should be used for preparing ozone injections.
Optimal dosmg is not always optimal for all patients. Our advice is to start with slightly lower dosmg and rises to the optunal after one-two injections . Higher doses are more painful than lower ones. Some patients can benefit from a slight higher dose. Please inject slowly, to avoid pain if possible. Protocols are not absolutely rigid. They can be adapted to each patients needs, but we recommend not to change the frequency of injections until some improvement lias been reached.
As ozone is a gas. we advice to use the thinnest needle possible (27G / 30G). to diminish the injection pam. Local anesthetics can be used, although topic anesthesia or even cryotherapy can be useful to avoid the pain produced by the injection. The ozone itself produce some degree of pain due to the radicals produced by the first chemical reactions. Some authors believe this pain is useful as it induces plasticity in the Central Nervous System, needed to control pam . Others disagree, as clinical results are also
BHOpsaraciLiEih AHTHOKCHjaHTH 20If Tcm 2. & gt-sl
good using local anesthesia in the point of injection prior to ozone injection . There are no publications up to now proving any of the controversial ideas. We even don'-t know if ozone can degrade theses substances m vivo (or irt vitro). Syringes should be ozone-proof: standard low-pressure syringes are siliconized, so they can be used for a single injection, as repeated use in the same patient can degrade silicone and produce plastic particles.
Glass syringes are optimal, but they are unpractical, as they need a re-sterihzation. Latex gloves can be used if there is low chance to produce ozone leak during the injection. Otherwise, vinyl gloves are better, as they are ozone-proof. Local infection close to the point of injection is a formal contraindication. Use of anti-platelets or anticoagulants is a formal contraindication when we inject into a cavity or a virtual space and 1KR. is equal or above 3. In these patients, the use of low-molecular-weight heparins is advised & quot-32]. General ozone therapy contraindication apply in all cases. This is not an infiltration manual, so technical description will be focused on ozone therapy related details of the injection procedure.
Tend inopiitli its a ad e n thesis t is
Due to its anti-inflammatory effects and the Lick of significant side effects, ozone can be used instead of steroids for local injections where we usually use them. It has been tried with success in shoulder tendmopatines [33−35]. tennis-elbow , D'-Quervam'-s tendinitis [37& quot-. trochanteric hip bursitis. and others. Global good esults for these pathologies are 80% [33−37]. Calcifications are not a contraindication .
L7se the thinnest and more suitable needle for the injection. Start with 15 ug-'-mL and rise to 20 in the second or third injection if possible. Remain at 20 ug-mL or even 25 if the pain of mjection is low. Amount of ozone depends on the target to treat. Small tendons can be injected peritendon vith 2−3 niL. Shoulder tendons can be injected with
5−10 mL depending on the tendons affected.
Trochanteric bursae can be injected with even 15 mL in big patients. In these patients, injecting along the ilio-tibial band may be useful if painful- look for painful pomts along the band and inject 2−3 mL per point. Careful examination of the patient should be performed to determine the pomts of injection before each session, as painful pomts may change, as usually more than one anatomical structure are involved in the process.
The protocol should be adapted to patients evolution. Injections should be performed on a weekly basis up to a number of 3−5. If there is no improvement after this time, treatment should be stopped. Total number can be higher, as injections can be done weekly meanwhile there is a clinical improvement. You will usually not need more than
6−3 injections to achieve a significant pam reduction . There is no need to go further, as the patient keep on improving during a month or more after the last injection. Some doctors inject twice a week but there is no benefit for the patient, as the treatment is not shortened in time and final number of injections is bigger & quot-39].
Other treatments combined with ozone have shown to be usefi. il. as physiotherapy . hyaluronic acid injections  or shock waves . We usually don'-t overlap other treatments, to clearly know which is the effect of ozone. Heat m the point of injection should be avoided at least for 48h as CT controls of paravertebral muscle injections
BnopiOHKCLiBi H AHTHO^CHjaHTti 2015 TCM 2. Nil
show presence of gas up to this period  and deep heat can produce gas volume to increase and produce pain.
Ozone injections have also widely used to treat knee osteoarthritis [6. 7, 42−54& quot-. There are few references to other locations, as hip [39, 53−56], shoulder or ankle. Severe osteoarthritis has been shown not to be a contraindication- theses patients improve almost the same as low grade osteoarthritis but the time free of symptoms is significantly shorter . Based on a rationale approach, severe deformities and misalignment can be considered as contraindications, unless no other option of treatment is available for the patient.
General dosing of the previous chapter apply for these patients. Amount of ozone per injection depends on the size of the joint and their compliance, using 10−15 niL for knee or shoulder, 5−3 for hip or ankle. Approach is well described in infiltration manuals . Careful exploration before each injection should be carried out. as in many cases the intrarticular disease has periarticular pathology, in form of enthesistis. bursitis or tendinitis. If this periarticular pomt are not treated with ozone or other complementary treatments, full success will not happen.
For pen articular injections, please follow the instructions in the proper chapter. Injections should be done on a weekly basis to avoid overdose, as referred in the previous chapter . Following this advices, good results range from 74%  to 60% . Other treatments can be used together or after ozone injections. For periarticular injections wre should respect the 48h window period. Intrarticular injections of hyaluronic acid  and rich-platelet plasma [57. 53] are being used together with ozone with encouraging results.
Nerve entrap ments
There are a few publications & quot-34. 35, 59] about the use of ozone injections in peripheral nerve entrapments as carpal tunnel or cubital tunnel syndrome. Although the basic physiopathology is the same of the pathologies in the previous chapters, neural tissue is more sensible to ozone, so lower doses must be used to reach a good result .
For carpal tunnel syndrome, the injection should be performed carefully permeurally with concentration of 5−7 |ig/mL and amounts of 3−5 mL. This dosing is. on a weekly basis, enough to get good results in near S0% of the patients. Papers on this topic are so scarce that we cannot asses which kind or severity is a contraindication. We advise to treat patients without severe motor deficit and non-progressive symptoms, but this a rationale advised not based in any evidence.
Tins pathology has been left to the end on purpose, as all the concepts shown in the previous chapters are true for spine diseases susceptible for ozone treatment and should be carefully evaluated and applied .
General indications for ozone treatment are:
— Disc herniation or disc-radicular conflict (CDR) as we prefer to define
— Degenerative disc disease (DDD)
— Grade I symptomatic spondylolisthesis
— Facet joint disease
bhopihhiciltei h ahthokcmahtbi 2015 tcm 2. nsl
— Facet joint osteoarthritis
— Lumbar spinal stenosis
The reader must have a deep knowledge on these pathologies and should know how to solve the possible complications of the use of ozone on them to guaranty the quality of the treatment and reach the highest level of success. Otherwise, he will not understand many points in this chapter, as explaining in detail the physiopathology of these pathologies is not the aim of this text.
We have to remember what has been explained m previous sections of this text. It is usually needed to treat satellite points of pain, specially in cervical pathology, where there are very common in the form of mio-fascial syndromes. In these cases, we can inject ozone m the pomts of pain in small amount (2−3 mL) at 10−15 ug/mL or treat with others pain techniques.
Regarding techniques and procedures, there are two mam ways of treatment for these pathologies.
The first one is the paravertebral approach. It was first described by Dr Verga  as a protocol used by him and his team named & quot-Discosan"- por treating lumbar disc herniation. The problem found after some years was the number of sessions of infiltrations was well above 15, so the length of the treatment [3 months] made some patients abandon the treatment To avoid this, Dr Scuccimarra , member of Dr Verga'-s team, developed the & quot-"-deep paravertebral injections& quot-, actually pen facet joint injections. This technique shortened considerably the number of sessions reducing them to 10 and up to a maximum of 15. Both techniques are basically para-spinal injections.
The classical paravertebral approach is done locating the upper part of the spinous process of the superior vertebrae involved in the CDR. and injecting 2.5 cm to the left and right of the spinous process with a 0.3×40 mm needle an amount of 5−10 mL per point depending on the size of the patient. Some authors [S3] have proved that using lower ozone concentration (10 ugmL) can be as useful as standard concentration (20 pg/mL). Our advice is to use a 0.4×40 mm needle or thinner if available.
Fig 1. Classical paravertebral injections
BHOpsaHKiLTbi H AHTHOKCHjaHiti 2015 TCM 2. & gt-sl
Fig 2. Deep paravertebral injections
Local, topic anesthesia or cryotherapy can be used to reduce the pain of the needle. Injection should be done slowly. Using local anesthesia in the muscle can reduce the effect of ozone injection. The & quot-deep paravertebral injection& quot- uses a similar procedure, but the distance from the middle line is narrower (1,5 cm for cervical and dorsal injection and 2 cm for lumbar injection) and it is necessary using longer needles (0.4 or 0.5×90 mm spinal needle) to be able to locate the postenor joints with the ftp of the needle an inject periarticularly. The amount of ozone used is the same.
It is also possible to inject over the laminae, close to the foramen, instead of around the facet joints, but risk of accidental dura or radicular puncture is greater (although without permanent side effects): this can be done for nerve root de-inflammation. Dr. Verga [64& quot- modified lus technique for cervical and dorsal disc herniation, narrowing the distance from the spinous process to 1.5 cm left and right, using shorter needles (25 or 30 mm) and decreasing the ozone volume per point to 3−7 niL. Dorsal approach uses the same technique as for cervical paravertebral injections. The second approach is the intradiscal — intra foramina 1 one . The idea  was taken from the chemonucleolysis with chemopapain, so the injection procedure has been inherited from it. Ozone has proved to induce dehydration in nucleus pulposus matenal [22. 23& quot-. so the intradiscal injection can help to alleviate the root compression . Moreover the ozone well proved anti-inflammatory effect can help to diminish disc, root, ganglia and periradicular tissue inflammation [67V
To obtain this combination of mechanical and biochemical effects, ozone should be injected intradiscal and intraforanimal in all cases, injecting around the affected root . Although in many cases we can see in the fluoroscope not only the gas discography but a gas leakage to epidural and periradicular space, this gas is oxygen with some molecules of ozone [or none] as the majority react immediately around the injection pomt: this is why we recommend to use both procedures when you want to get both mechanical and biochemical effect. The technique is well described in many manuals so we will center on teclinical details related to ozone therapy.
We, as always, advice to use thin needles, as the 22 G x 11& quot-'- Chiba needle for both procedures in lumbar disc. For cervical disc, 25G x 3*4'-& quot- is a good choice for intradiscal injection: for intra foramina 1 injection we advice to use pen tip needle — same size — to avoid accidental root, medulla or vertebral artery puncture. Imaging guidance is mandatory: CT or fluoroscope. Local anesthesia is mandatory for lumbar disc, as in
Биорадикалы и Антиоксиданты 2015 Том 2. № 1
some cases we need to change the needle position and we avoid pam in this situation. Sedation is optional, as some authors don'-t use it, but the authors advice using a light sedation to make this procedure more comfortable for the patient and the doctor.
After reviewing many publications, not only the animal investigation papers, but the clinical reviews, intradiscal concentration can range from 25 pg niL [23. 69. 70] to 40 pg/mL [71−74]: greater concentrations produce better results [72, 75. 76]. Some authors from China  even use 50 or 60 ug mL. but all animals models have shown annulus disruption secondary to concentrations of 50 pg/mL or more , so we advice not using concentrations over 40 ugniL.
Ozone volume for mtradiscal cervical injection [24, 77] should be 1−2 mL and for lumbar disc. 5−7 mL . Intra foramina 1 approach for requires 5 mL volume for cemcal mjection and 15 mL for lumbar injection [65, 69. 70. 78−80]. Dorsal approach, as in cervical paravertebral technique, is quite less frequent. In thin patients, the cemcal needle can be used: for bigger patients, the lumbar C'-hiba needle is a good choice. Ozone volumes are for mtradiscal are 2−3 mL and for intraforammal. 7−10 mL.
Fig 3. Intradiscal injection
Fig 4. Intraforammal injection
For lumbar radiculopathy, Dr Mattozzi [SI] proposed caudal epidural ozone injections with standard pen tip needle and introducer, usually 27G x 3V2& quot-, with 20 mL of ozone at 20 ug mL each two weeks up to 4−5 times. There are a few publications on this , but authors'- personal experience is promising and it is under heavy investigation.
EHOpJHHKiOEi H AEiHOKCHjaHrbi 2015 TCM 2. Nsl
a) Disc-radicular conflict.
In these patients, the problem is centered on the CDR problem. The indication for treatment is the same as for surgery. so in case of severe neurological symptoms we prefer to start with intradiscal-intraforaminal approach [44. 65, S3-S6V unless there is a contraindication [annulus calcification or spondylosis]. A couple of days after, we proceed with paravertebral injections, twice a week up to six or eight. Depending on the spine pain, or the presence of facet joint pain, the technique can be classical or '-& quot-deep"-. For strong neurological symptoms, deep periforaminal injections can be used.
In patients with more spine pam than radicular pam. paravertebral technique can be used twice a week. If after 4−5 session there is no improvement, intradiscal-intraforaminal technique should be used. Otherwise, paravertebral can be kept on up to 10−12 sessions. No further should we go if there is no improvement. In these cases, we should recheck the patient.
b) Degenerative disc disease (DDD)
It is difficult to reach this diagnose, because patients with DDD usually have spondylosis or facet joint problems. Isolated DDD can only be diagnosed by discomanometry. Use of ozone in this pathology is not well documented. Author'-s opinion is using mtraforanimal approach, repeated if needs 2 or 3 times each 2 wreeks. Deep paravertebral injections twice a week up to 10−12 session is an option. However, there is no bibliography to support this as DDD is not a frequent diagnose.
In case of concomitant pathology, these should be treated as indicated in the next chapters.
c) Grade I symptomatic spondylolisthesis
The only papers about this are the ones from Dr. Bonetti [S7. 8S]. He used CT guided injection into pars articularis of 2−3 ml of ozone at 20 ng. '-mL. one or two times. Results are maintained at least for one year.
Treating degenerative spine is a growing indication of spinal ozone therapy [S9−92]. There are few publications about this, but the number is increasing. Cervical and lumbar spondylosis are frequently related ivith facet jonit osteoarthritis- dorsal spondylosis is usually isolated because ribs protection factor.
As commented before, concomitant pathology should be also treated. These patients usually only suffer from spine pam, so we use classic paravertebral injections together with perifacet joint niiections in case of facet problem, usually present for cervical and lumbar spine. Ten sessions, twice a iveek and then go on with 2−5 more sessions, once a week. It is usually a long treatment so is better to tell the patient before starting to avoid treatment abandon.
Some authors prefer to use CT-guided facet joint injections instead of deep paravertebral ones. It depends on availability and cost. Technical details are the same as for spondylolisthesis. In case of radicular pam others diagnoses should be considered, as facet joint cyst or lumbar spinal stenosis.
e) Facet joint disease
There is no reference published about tins. Mechanical factors should be corrected first. Afterwards, in case of persistent pain and failure of other conservative treatments, classical paraveterbral or deep perifacet joint injections procedure can be used, twice a
EHOpiHHKitiBi H AHiHO^CHjafiTti 2015 TCM 2. al
week up to LG-12 sessions. CT-guidance injections are an option, as treatment can be shortened theoretically, but witli an increase in cost.
f) Facet joint osteoarthritis
Few references are found in bibliography about tins indication, usually related with spondylopathy.
As in the former chapter, the choices are classical paravebral. deep perifacet joint or CT-guided facet joint injections. The first one is the least ethiological treatment and the last one is the optimal, if cost is not a problem. We don'-t have enough evidence to advice one over the rest.
g) Lumbar spinal stenosis
Only a couple of papers have been published on this topic [90. 93]. Approach can be done through intra foramina 1 + perifacet joint CT- guidance injections or through deep paravertebral injections. Hie first choice is more expensive, technical demanding but short in time. The second is more simple but more time consuming and takes more time to finish the treatment. Results published are similar for both techniques.
Epidural ozone injection through sacrum hole together vith perifacet jomt injection without direct imaging guidance is under evaluation and preliminary reports are promising.
Non-rheumatic locomotor system pathologies are nowadays the more scientifically supported indication for ozone therapy.
It is a safe and effective treatment that is resisting any comparison published. Moreover, the cost of the treatment is cheap so it is likely that a cost-effective study could prove that it is one of the best treatments for these pathologies, even better that systemic drugs treatments.
Side effects are small and always related to defective technique, so it is mandatory to be well trained to perform these approaches.
More clinical trials are needed to achieve higher level of evidence in non-spine indications.
1. Verga C. Nuovo approccio terapeutico alle emie e protusioni discali lombari //Rrvista Di Neuroradiology. 19S9. Vol. 2. P. 143.
2. Riva Sanseverino E. Knee joint disorders treated by oxigen-ozone therapy // Europa Medicophysica. 19& amp-9. Vol. 25. N3. R 163−170.
3. Escarpenter J. Valdes O. Resultados terapeuticos en la osteoartritis de la rodilla con infiltraciones de ozono // Revista Cub ana de Investigation Biomedica 1997. Vol. 16. P. 124−132.
4. Gheza G. Ipprio L., Bissolotti L. Oxygen-Ozone Therapy in a Diabetic Patient with De Quervain'-s Tenosynovitis Associated with Jomt Arthrosis // Riv. Ital. Ossigeno-Ozonoterapia. 2002. Vol. 2. N1. P. IS9−192.
5. Gaffuri M. Garaffo R. Gheza G. Oxygen-Ozone Therapy for Lateral Humeral Epicondylitis: Preliminary Findings // Riv. Ital. Ossigeno-Ozonoterapia. 2003. Vol. 2. N2. P. 169−172.
6. Gheza G. Bissolotft L. Intra-articular Oxygen-Ozone Injection for Knee
EHOpsoHEiLT& amp-i H AHTHOfcciuaHTbi 2015 TCM 2. & gt-sl
Disease Proposed Guidelines fi Ri v. Ital. Ossigeno-Ozonoterapia. 2003. Vol. 2. N1. P. 63−66.
7. Moretti B. Lanzisera R. M ores e A. et al. 02−03 vs Chondroprotectors in the Treatment of Osteoarthritis of the Knee /'-/'- Riv Ital Ossigeno-Ozonoterapia. 2004 Vol. 3. N1.P. 65−72.
8. Pribluda S. Treatment of Lumbosciatica and Other Similar Syndromes with Subcutaneous Ozone// Sem. Med. 1963. Vol. 123. P. 1026−1028.
9. Magalhaes E. Dotta L. Sasse A. Ozone therapy as a treatment for low back pain secondary7 to herniated disc: a systematic review and meta-analysis of randomized controlled trials // Pa m Physician. Vol. 15. N2. P. Ell 5−129.
10. Ceccherelli F., Gagliardi G. Faggian L. et al. Analgesic effect of subcutaneous administration of oxygen-ozone. A blind study in the rat on the modulation of the capsaicin-induced edema // Acupunct. Electrother. Res. 1993. Vol. 23. N3−4. P. 171−184.
11. Iliakis E.M. Valadakis V. Vynios D. et al. Rationalization of the activity of medical ozone on intervertebral disc: a histological and biochemical study // Rivista di Neuroradiologia. 2001. N14. Suppl. 1. P. 23−30.
12. Iliakis E. Petropoulos L, Iliaki A. et al. Is Medical Ozone Safe when Injected Intra-articularly? /7 International Journal of Ozone Therapy. 2003. N7.
13. Bm Yu. Ozone treatment in osteoarthritis- basic and clinical investigation U Proc. of the IV Meeting of the CFOT (Internet). Shenyang: 2012. http: //www. cfot. oig. cn/new s_view. asp? id=3 64
14. Kim Y. Jeon B., Kwon K. Ozone Chemonucleolysis on the Lumbar Intervertebral Disc of the Rabbit ii J. Korean Neurosurg. Soc. 2003. Vol. 34. N6. P. 570 574.
15. Li S., Yu G. Chen G. Impact of different concentrations of ozone injection on pathological changes of rabbit skeletal muscle H J. Modem Clin. Med. Bioeng. (Internet). 2006. N6. http: //en. cnki. com. cn/Article_en/CJFDTOTAL-XDLC200606012. htm
16. Castrini A. Prignacca E. Treatment Protocol for Herniated Disc with Oxygen-Ozone Therapy in Dog ii Riv. Ital. Ossigeno-Ozonoterapia. 2002. Vol. 1. N1. P. 113−115.
17. Yu Z., He X. Chen Y. Influence of ozone on the ultrastructures of nucleus pulposus ii J. Intervent. Radiol. (Internet). 2001. N3. http: /'-- en. cnki. com cn/Article_enCJFDTO TAL — JRFS 200 103 017. htm
IS. Yu Z., He X., Chen Y. et al. // Chin. J. Radiol. [Internet]. 2002. Vol. 50. N4. http: /'- en. cnki com cn'-Article_en-'-CJFDTOTAL-ZHGS200204023. htm
19. Algara C. Garcia O. Oxygen-ozone percutaneous nucleolysis: an animal model study ii Proc. of the 1st world congress on minimally spuie sur gen- Honolulu: 2003.
20. Muto M. Intra discal and Intramuscolar Injection of Oxygen-Ozone: Pathological Evaluation. Work m Progress ¦¦ Riv. Ital. Ossigeno-Ozonoterapia. 2004. Vol. 3. N1.P. 7−13.
21. Tian J. Zhang J-Sh., Xiao Y. et al. Oxidanve effect of different concentration of ozone injected into porcine normal lumbar disks ii Chin. J. Intervent.
BHOpiQHKfLTBi H AHTHOKCHjaHTH 2015 TCM 2.
Imaging Ther. (Internet). 2007. N4. http: — en. ciiki. com. civ'-Article_en-, CJFDTOTAL-JRYX200704018. htm
22. Alexandre A., Buric J. Paradiso R. et al. Intradiseal injection of 02−03 to treat lumbar disc herniations ¦ ¦'- Riv. Ital. Ossigeno-Ozonoterapia. 2002. Vol. 1. N2. P. 165−169.
23. Andreula C. Muto M. Leonardi M. Interventional spinal procedures // Eur. J. Radiol. 2004. Vol. 50. N2. P. 112−119.
24. Alexandre A., Coro L. Azuelos A. et al. Intradiseal injection of oxygen-ozone gas mixture for the treatment of cervical disc herniations .7 Acta Neurochir. 2005. Vol. 92. Suppl. P. 79−82.
25. Tian J.L. Zhang J.S. Xiao YY. et al. Changes of CSF and spinal pathomorphology after high-concentration ozone injection into the subarachnoid space: an experimental study in pigs // AJNR Am. J. Xeuroradiol. 2007. Vol. 23. N6. P. 10 511 054.
26. Yu B. Lin Q. -R. Wang B -W. et al. Effect of Intra-Articular Ozone Injection on Degenerative Knee Cartilage in Rats // Int. J. Ozone Ther. 2010. Vol. 9. N1. P. 14−20.
27. Paoloni M. Di Sante L. Cacchio A. et al. Intramuscular oxygen-ozone therapy in the treatment of acute back pain with lumbar disc herniation: a multicenter, randomized, double-blind, clinical trial of active and simulated lumbar paravertebral injection // Spine. 2009. Vol. 34, N13. P. 1337−1344.
2S. Steppan J. Meaders T. Muto M. Murphy K. A metaanalysis of the effectiveness and safely7 of ozone treatments for herniated lumbar discs II J. Vase. Interv. Radiol. 2010. Vol. 21. N4. P. 534−54S.
29. Bocci V. General mechanisms of action of ozonetherapy and pam related mechanism //Rev. Esp. Soc. Dolor. 2005. Vol. 12. N II. P. 24−36.
30. Bocci V. Ozone: A new medical drug (Internet). Netherlands: Springer. 2005. 295 p.
31. Lopez-Laserna Ruiz J. Results of Conservative Treatment of Tarsal Tunnel Syndrome: Medical Ozone Infiltration and Surgery ¦ ¦¦'- Revista Espanola de Ozonoterapia. 2012. P. 62.
32. Garcia-Gonzalez B. Garcia-Munoz W., Jativa-Silvestre F. Infiltraciones locales en Cirugia Ortopedica y Traumatologia. Manual de Cirugia Ortopedica y
Traumatologia — SE COT. 2a ed. Madrid: Editorial Medica Panamericana: 2010. P. 334 342.
33. Gjonovich A., Girotto L. Sattin G. et al. Oxygen-Ozone Therapy in Shoulder Pain: Clinical Experience //Riv. Ital. Ossigeno-Ozono terapia. 2002. Vol. 1. N1. P. 37−40.
34. Moretti B. Lanzisera R. Sisti G.L. et al. 02−03 therapy in tendinopathies and entrapment syndromes ¦¦ Riv. Ital. Ossigeno-Ozonoterapia. 2005. Vol. 4. N1. P. 2029.
35. De Lucas J. Ozone peripheric al infiltration. Indications, techniques and clinical experience If Rev. Esp. Soc. Dolor. 2005. Vol. Vol. 12. NII. P. 37−47.
36. Moretti M. Can Oxygen-Ozone Injections in Sport Overuse Tendinopathies Be a Valid Alternative to Cortisone Therapy? I i Int J Ozone Ther. 2010. Vol. 9. N1. P. 21-
BnopiHHKCinbi H ABTHOKCHjaHTti 201 i TCM 2. JVsl
37. Moretti M. Effectiveness of Oxygen-Ozone and Hyaluronic Acid Injections in De Quervain s Syndrome // Int. J. Ozone Ther. 2012. Vol. 11. N1. P. 31−33.
36. Trenti G. Gheza G Efficacy of Oxygen-Ozone Pain Therapy Associated with Shock Waves to Treat Calcifying Tendinitis of the Shoulder // Riv. Ital. Ossigeno-Ozonoterapia. 2002. Vol. 1. N1. P. 45−50.
39. Benvenuti P. Oxygen-Ozone Treatment of the Knee. Shoulder and Hip // Riv. Ital. Ossigeno-Ozonoterapia. 2006. Vol. 5. N2. P. 135−144.
40. Ikonomidis S. Caralambus D., Vakirtzian L. Iliakis E. Nonoperative Treatment of Shoulder Impingement Syndrome with Topical Injections of Medical Oxygen-Ozone Mixture. A double blind clinical trial //Riv. Ital. Ossigeno-Ozonoterapia. 2002. Vol. 1. XI. P. 41−44.
41. Bonetti M. Oxygen-ozone therapy vs epidural steroids injections — CT evaluation U Rivista Di Neuroradiology. 2000. Vol. 13 N2. P 203−206.
42. Baeza-Noci J. Ozonoterapia mtrarticular en la gonartrosis // II Curso TeoncoACEOOT. Jerez dela Frontera: 2006.
43. Huanqi C. Cruz M. Eficacia y seguridad del ozono intraarticular en artrosis de rodilla refractaria al tratamiento ¦¦ Rev. Per. Reuni. 2006. Vol. 12. N1. P. 21−26.
44. Baeza-Noci J. Guideline for ozone therapy in degenerative joint diseases .7 II Meeting of the CFOT. Urumqi. 20OS.
45. Rogelio Milanes J. Acosta Rivera W. Trinchet Avala E. Hernandez Rosales F. The ozonotherapy/Results of the treatment in patients with symptomatic degenerative arthrosis of the knee // Dolor. Clinica y Terapia. 2009. Vol. 6. N4. P. 13−24.
46. Baeza-Noci J. Osteoartrosis de rodilla. Resultados de la ozonoterapia // II Congreso Nacional S EOT. Marbella: 2009.
47. Guo D. Zhang X. Study on treatment for knee osteoarthritis by medical ozone ¦¦/ Gansu M ed. J. 2 010. N1. P. 10−11.
46. Moretti M. Effectiveness of Treatment with Oxygen-Ozone and Hyaluronic Acid m Osteoarthritis of the Knee // Int. J. Ozone Ther. 2010. Vol. 9. N1. P. 25−29.
49. Wang J. Zhang Y. Ma Y Therapeutic Effect of Low Concentration Medical Ozone on Knee Osteoarthritis // J. Liaomng Coll. Tradit. Chin Med. 2010. Vol. 12. N4. P. 17−19.
50. Baeza-Noci J. Knee osteoarthritis: ozone therapy results ¦¦ IV International Ozone Congress. Dehli. 2010.
51. Mishra S.K. Pramanik R., Das P. et al. Role of intra-articulra ozone m osteo-arthritis of knee for functional and symptomatic improvement? i End. J. Phys. Med. Rehabllit. 2011. Vol. 22. N2. P. 65−69.
52. Ay male CA. Ozonoterapia en patologia artrosica quirurgica de rodilla Ozone therapy in surgical pathology of arthritic knee ?? Rio de Janeiro (Brazil). 2011.
53. Baeza-Noci J. Ozonoterapia en la gonartrosis y la coxartrosis Ozonetherapy in osteoarthritis ¦¦ Rio de Janeiro (Brazil). 2011.
54. Baeza-Noci J. Ozonoterapia en la gonartrosis y la coxartrosis ¦¦ XXXIV Congreso de la SffiB. Cordoba, 2011.
55. Baeza-Noci J. Ozonoterapia en la patologia de cadera del adulto ¦¦ IX Congreso de la ACEOOT. Granada. 2011.
BnopiOHEiiiBi H AaiHOfccmaHTbi 2015 TCM 2. & gt-sl
56. Baeza-Noci J. Ozone therapy ni adult hip pathology // III Meeting of the WFOOT Brescia. Italy: 2011.
57. Cabot Dalinau J. Combined Technique of Ozontherapy and Platelet Derived Growth Factors in the Knee Osteoarthritis (Tecnica Combinada de Ozonoterapia y Factores de Crecimiento en la Artrosis de Rodilla) // Revista Espanola de Ozonoterapia: 2011. P. 34−35.
5S. Baeza-Noci J. Ozone and rich-platelet plasma: a good team for knee osteoarthritis. IV Meeting of the CFOT. Shenyang- 2012.
59. Zambello A., Fumagalli L. Far a B., Bi anchi M. Oxygen-Ozone Treatment of Carpal Tunnel Syndrome. Retrospective Study and Literature Review of Conservative and Surgical Techniques ii International Journal of Ozone Therapy. 20OS. Vol. 7. N1. P. 45−4S.
60. Bocci V. Is it true that ozone is always toxic? The end of a dogma ¦ ¦'- Toxicol. Appl Pharmacol. 2006. Vol. 216. N3. P. 493−504.
61. Baeza-Noci J. Ozone spinal infiltration. Pliysiopatliology and mechanism of action Rev Esp Soc Dolor. 2005. Vol. 12. P. IS-23.
62. S eue cimarra A. The & quot-"-Lannnoforaniinal Technique& quot- m Oxygen-Ozone Therapy for Lumbar Disc Herniation? I Riv. Ital. Ossigeno-Ozonoterapia. 2003. Vol. 2. N2. P. 193−196.
63. Zambello A. F ara B., Bianchi M., Tabaracci G. Paravertebral Oxygen-Ozone Infiltrations: High versus Low Doses: towards the Minimum Effective Dose // Int. J. Ozone Ther. 2007. Vol. 6. N1. P. 37−41.
64. Verga C. II perche ed il come dell'-ossigeno ozono nel trattamento della patologia ortopedica i i Ossigeno Ozono Terapia: Pratica medica tra certezze e prospettive terapeutiche. Sorrento: 2004.
65. Mu to M., Andreula C Leonardi M. Treatment of herniated lumbar disc by intradiscal and intraforaminal oxygen-ozone [02−03] injection i i J. Neuroradiol. 2004. Vol. 31. N3. P. 1S3−1S9.
66. Juncopilla N., Franzini M. Hie therapy involving the infiltration of oxygen-ozone intra disc and mterfacet /7 1er Congre sso de la Sociedad Espanola de abordajes percutaneos vertebrales. Barcelona: 1995.
67. Da 11& quot-aglio R. Gomez Moraleda M., Cardoso C. et al. Biochemical and Pharmaceutical Aspects of Entrapment: the Possible Role of Free Radicals and Ozone m Nerve Root Compress ion-¦ Riv. Ital. Ossigeno-Ozonoterapia. 2004. Vol. 3. N2. P. 105 111.
6S. Murga M. Ozone spinal infiltration. Indications, techniques and clinical experience! f Rev. Esp. Soc. Dolor. 2005. Vol. 12. NII. P. 10−17.
69. Leonardi M. Disc Puncture under Fluoroscopic Guidance // Riv. Ital. Ossigeno-Ozonoterapia. 2002. Vol. 1. N 1. P. 73−7S.
70. Andreula C.F. Simonetti L. De Santis F. et al. Minimally invasive oxygen-ozone therapy for lumbar disk herniation // AJNR Am. J. Neuroradiol. 2003. Vol. 24. N5. P. 996−1000.
71. He X., Yu Z. Teng G et al. Treatment of lumbar disc herniation by using percutaneous intradiscal and paraspmal space injection of 0 2−0 3 mixture fi Chin. J. Radiol. (Internet). 2003. N9. Retrieved from:
BnopiQHiciLTEi H AHiHO^CHjaHTBi 2015 TCM 2. Nil
http: //eu. cnki. com cn. Article_en CJEDTO TAL -ZHGS2 00 3 0 901S. htm
72. Buric J. Molino Lova R. Ozone chemonucleolysis in non-contained lumbar disc herniations: a pilot study with 12 months follow-up ¦¦ Acta Neurochir. Suppl. 2005. Vol. 92. P. 93−97.
73. He X.R. Yu Z J. Li YH. et al. Percutaneous injection of intradiseal and paraspinal space with 02−03 mixture to treat lumbar disc herniation // Riv. Ital. Ossigeno-Ozonoterapia. 2003. Vol. 2. N2. P. 135−133.
74. He X. Li Y. Chen H. et al. Intradiscal mjection of 02−03 to treat lumbar disc herniations: clinical therapeutic effect analysis with 600 cases ¦¦ Chin. J. Entervent. Imaging Ther. (Internet). 2005. Vol. 2. N5. http: //en. cnki. com. cn-'-Article_en-CJFDTotal-JRYX200505004. htm
75. Buric J., Alexandre A., Coro L. Azuelos A. Intradiscal Ozone Treatment of Non-Contained Disc Herniations. 13 Months Follow-up .7 Riv. Ital. Ossigeno-Ozonoterapia. 2003. Vol. 2. N2. P. 153−160.
76. Wang J. Li H. Wang G. Studies on the concentration of oxygen-ozone m percutaneous intradiscal oxygen-ozone-injection for the treatment of lumber disc herniation Chin. J. Spine Spinal Cord (Internet). 2007. N11. ttp: //en. enki. com. cn- Article_eu/C JFD TOTAL-Z JZ S200711010. htm
77. Paradiso R. Alexandre A. The different outcomes of patients ivith disc herniation treated either by microdiscectomy or by intradiscal ozone injection // Acta Neurochir Suppl. 2005. Vol 92. P 139−142
7S. Bonetti M. CT-Guided Intraforaminal Technique // Riv. Ital. Ossigeno-Ozonoterapia. 2002. Vol. 1. N1. P. 69−71.
79. Andreula C Lumbosacral Herniated Discs: Chemodiscolysis with Nucleophthesis with 02−03 and Peritadicular and Periganglionic Infiltration under CT Guidance Personal Experience // Riv. Ital. Ossigeno-Ozonoterapia. 2002. Vol. 1. XI. P. 79−65.
30. Andreula C. Ozone therapy // Neuroradiology. 2011. Vol. 53. Suppl. 1. P. S207−209.
31. Mattozi I. Laurini G, Muzzi G. et al. Intra sacral epidural injection with oxygen-ozone for the treatment of low back pain. Comparison and evaluation with other techniques and rehabilitation and return to work // European Journal of Clinical Investigation. 2003. Vol. 33 [suppl. 1]. P. 45.
32. Morales E. Peridural ozone therapy in disc-radicular conflcit and lumbosciatalgia //Jornadas Cientificas SEOT 2012. Valencia: 2012.
33. Baeza-Noci J. Spmal ozone therapy — state of the art // Congreso Nazionale FIO. Bologna: 2007.
34. Baeza-Noci J. Rational use of ozone therapy in degenerative spinal pathologies// 6th European Course & quot-Minimally invasive surgery of the spine. "-"- Treviso: 2003.
35. Baeza-Noci J., Kumar V Ozone discectomy (ozonucleolysis) for discogenic radiculopathy arising from disc herniation: one year follow-up study from Indian and Spanish centres. Spineiveek. Geneve: 200S.
36. Baeza-Noci J. Ozone Therapy in the Musculo-Skeletal Pathology: Spine // III Meeting of the WEOOT. Brescia, Italy: 2011.
EHOpJOHKca& amp-i h AHiHotiCHjaHTbi 2015 TCM 2. Nsl
87. Bonetti M. CT-Guided Oxygen-Ozone Infiltration into Isthmic Lysis Points m the Management of 1st Degree Spondylolisthesis and Spondylolysis // Riv. Ital. Ossigeno-Ozonoterapia. 2003. Vol. 2. N1. P. 31−38.
8S. Bonetti M. Fontana A. Albertini F. CT-guided oxygen-ozone treatment for first degree spondylolisthesis and spondylolysis ¦¦'- Acta Neiirochir. Suppl. 2005. Vol. 92. P. S7−92.
89. Bonetti M. Cotticelli B. Ricbelmi P. Valdenassi L. Rofecoxib and 02−03 Therapy vs 02−03 Therapy in the Management of Spondylarthrosis ¦¦ Riv. Ital. Ossigeno-Ozonoterapia. 2002. Vol. 1. N2.P. 171−17S.
90. Bonetti M. Fontana A. Mardighian D. Oxygen-ozone therapy for degenerative spine disease in the elderly // Riv. Ital. Ossigeno-Ozonoterapia. 2006. Vol. 5. N1. P. 25−32.
91. Bonetti M., Fontana A. Parodi F. Oxygen-Ozone Therapy Associated with Magnetic Bioresonance m Degenerative Arthrosis of the Spme: Preliminary Findings // Int. J. Ozone Ther. 2007. Vol. 6. N1. P. 29−35.
92. Bonetti M. Fontana A. Martmelli F., Andreula C. Oxygen-ozone therapy for degenerative spme disease in the elderly: a prospective study // Acta Neiirochir. Suppl. 2011. Vol. 108. P. 137−142.
93. Baeza-Noci J. Spmal Ozone Therapy in Lumbar Spinal Stenosis // Int. I. Ozone Ther. 200 7. Vol. 6. N1. P. 17−24.